ResearcherNebraska Medical CenterActive in the last 2 years
Muzafar Ahmad Macha
Matched on ORCID iD 0000-0003-4468-4435; OpenAlex author ID A5059751626. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 42
2012: 2 papers · 2013: 2 papers · 2014: none · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 11
- NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis. Co-author DOI 10.1016/j.canlet.2026.218269↗
- Integrated transcriptomic and functional characterization of Claudin-1 reveals its oncogenic and immunomodulatory roles in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/21688370.2026.2648150↗
- Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.canlet.2024.217097↗
- Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2019.03.056↗
- The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.molonc.2015.10.005↗
- Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. First author DOI 10.1016/j.addr.2014.10.020↗
- Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. First author DOI 10.18632/oncotarget.5641↗
- Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Co-author DOI 10.1016/j.canlet.2013.03.017↗
- Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Co-author DOI 10.1016/j.canlet.2013.07.037↗
- MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. First author DOI 10.1093/carcin/bgs225↗
- Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Co-author DOI 10.1186/1756-8722-5-68↗
Closest collaborators
The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 10 shared papers, 2012–2026 · strength 0.86
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097↗
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Jesse L. Cox · 2 shared papers, 2024–2026 · strength 0.47
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097↗
- Satyanarayana Rachagani · 8 shared papers, 2012–2019 · strength 0.39
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Paper The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. DOI 10.1016/j.molonc.2015.10.005↗
- Paper Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. DOI 10.1016/j.addr.2014.10.020↗
- Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2012–2024 · strength 0.36
- Paper Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal… DOI 10.1016/j.canlet.2024.217097↗
- Paper The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. DOI 10.1016/j.molonc.2015.10.005↗
- Paper Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src… DOI 10.1016/j.canlet.2013.07.037↗
- Koelina Ganguly · 2 shared papers, 2019–2026 · strength 0.35
- Imayavaramban Lakshmanan · 2 shared papers, 2016–2026 · strength 0.33
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. DOI 10.1016/j.molonc.2015.10.005↗
- Apar Kishor Ganti · 2 shared papers, 2013–2026 · strength 0.31
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro an… DOI 10.1016/j.canlet.2013.03.017↗
- Rahat Jahan · 2 shared papers, 2019–2024 · strength 0.28
- Pranita Atri · 2 shared papers, 2019–2024 · strength 0.28
- Sanjib Chaudhary · 1 shared paper, 2026 · strength 0.27
- Ramesh Pothuraju · 1 shared paper, 2026 · strength 0.27
- Subodh M. Lele · 1 shared paper, 2026 · strength 0.27
- Anju Surendranath · 1 shared paper, 2026 · strength 0.25
- Rashid Mir · 1 shared paper, 2026 · strength 0.25
- Shahab Uddin · 1 shared paper, 2026 · strength 0.25
- Ajaz A. Bhat · 1 shared paper, 2026 · strength 0.25
- Punita Dhawan · 1 shared paper, 2026 · strength 0.25
- Lynette M. Smith · 3 shared papers, 2015–2019 · strength 0.20
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Paper The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. DOI 10.1016/j.molonc.2015.10.005↗
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Palanisamy Nallasamy · 1 shared paper, 2024 · strength 0.20
- Sushil Kumar · 1 shared paper, 2024 · strength 0.20
- Ashu Shah · 1 shared paper, 2024 · strength 0.20
- Sophia G. Kisling · 1 shared paper, 2024 · strength 0.20
- Priya Pai · 3 shared papers, 2013–2016 · strength 0.16
- Paper The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. DOI 10.1016/j.molonc.2015.10.005↗
- Paper Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered… DOI 10.18632/oncotarget.5641↗
- Paper Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src… DOI 10.1016/j.canlet.2013.07.037↗
- Sukhwinder Kaur · 3 shared papers, 2012–2019 · strength 0.15
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Paper Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro an… DOI 10.1016/j.canlet.2013.03.017↗
- Paper Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diag… DOI 10.1186/1756-8722-5-68↗
- Dhanya Haridas · 3 shared papers, 2012–2015 · strength 0.12
- Paper Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. DOI 10.1016/j.addr.2014.10.020↗
- Paper MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor r… DOI 10.1093/carcin/bgs225↗
- Paper Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diag… DOI 10.1186/1756-8722-5-68↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.